Leuko
1 known investors
Leuko develops PointCheck, a noninvasive, finger-based at-home device that measures white blood cell levels using optical imaging and AI, designed to help cancer patients and clinicians monitor infection risk. The portable test brings immune-system monitoring out of clinical laboratories into patient homes.
Investors · 1
Frequently asked questions
- What does Leuko do?
- Leuko develops PointCheck, a noninvasive, finger-based at-home device that measures white blood cell levels using optical imaging and AI, designed to help cancer patients and clinicians monitor infection risk. The portable test brings immune-system monitoring out of clinical laboratories into patient homes.
- Who are Leuko's investors?
- Leuko's investors include Nina Capital.